Biomedicines (Apr 2024)

Myocardial Ischemia–Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies

  • Marios Sagris,
  • Anastasios Apostolos,
  • Panagiotis Theofilis,
  • Nikolaos Ktenopoulos,
  • Odysseas Katsaros,
  • Sotirios Tsalamandris,
  • Konstantinos Tsioufis,
  • Konstantinos Toutouzas,
  • Dimitris Tousoulis

DOI
https://doi.org/10.3390/biomedicines12040802
Journal volume & issue
Vol. 12, no. 4
p. 802

Abstract

Read online

Myocardial ischemia–reperfusion injury (MIRI) remains a challenge in the context of reperfusion procedures for myocardial infarction (MI). While early revascularization stands as the gold standard for mitigating myocardial injury, recent insights have illuminated the paradoxical role of reperfusion, giving rise to the phenomenon known as ischemia–reperfusion injury. This comprehensive review delves into the intricate pathophysiological pathways involved in MIRI, placing a particular focus on the pivotal role of endothelium. Beyond elucidating the molecular intricacies, we explore the diverse clinical manifestations associated with MIRI, underscoring its potential to contribute substantially to the final infarct size, up to 50%. We further navigate through current preventive approaches and highlight promising emerging strategies designed to counteract the devastating effects of the phenomenon. By synthesizing current knowledge and offering a perspective on evolving preventive interventions, this review serves as a valuable resource for clinicians and researchers engaged in the dynamic field of MIRI.

Keywords